Compare LACTOSE INDIA with RELISH PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs RELISH PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA RELISH PHARMA LACTOSE INDIA/
RELISH PHARMA
 
P/E (TTM) x -85.0 402.1 - View Chart
P/BV x 1.3 0.9 152.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LACTOSE INDIA   RELISH PHARMA
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
RELISH PHARMA
Mar-20
LACTOSE INDIA/
RELISH PHARMA
5-Yr Chart
Click to enlarge
High Rs4261 68.4%   
Low Rs1626 62.0%   
Sales per share (Unadj.) Rs30.663.4 48.2%  
Earnings per share (Unadj.) Rs-2.20.2 -944.7%  
Cash flow per share (Unadj.) Rs1.69.6 17.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs30.198.2 30.7%  
Shares outstanding (eoy) m11.441.57 728.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.90.7 138.4%   
Avg P/E ratio x-13.3191.4 -7.0%  
P/CF ratio (eoy) x17.64.5 391.2%  
Price / Book Value ratio x1.00.4 217.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m33068 486.0%   
No. of employees `000NANA-   
Total wages/salary Rs m10643 245.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m350100 351.1%  
Other income Rs m30 3,130.0%   
Total revenues Rs m353100 353.9%   
Gross profit Rs m6216 379.2%  
Depreciation Rs m4415 294.9%   
Interest Rs m540 272,400.0%   
Profit before tax Rs m-332 -1,912.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-81 -587.4%   
Profit after tax Rs m-250 -6,883.3%  
Gross profit margin %17.816.5 108.0%  
Effective tax rate %24.279.1 30.7%   
Net profit margin %-7.10.4 -1,982.1%  
BALANCE SHEET DATA
Current assets Rs m197145 136.3%   
Current liabilities Rs m11670 166.4%   
Net working cap to sales %23.175.0 30.8%  
Current ratio x1.72.1 81.9%  
Inventory Days Days592 3,079.2%  
Debtors Days Days671291 230.3%  
Net fixed assets Rs m686191 359.5%   
Share capital Rs m11416 730.3%   
"Free" reserves Rs m230138 166.5%   
Net worth Rs m345154 223.8%   
Long term debt Rs m39381 487.6%   
Total assets Rs m883335 263.4%  
Interest coverage x0.486.5 0.5%   
Debt to equity ratio x1.10.5 217.9%  
Sales to assets ratio x0.40.3 133.3%   
Return on assets %3.40.1 2,995.0%  
Return on equity %-7.20.2 -3,110.0%  
Return on capital %3.00.7 400.7%  
Exports to sales %00-   
Imports to sales %7.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m26NA-   
Fx inflow Rs m250 245,500.0%   
Fx outflow Rs m273 1,044.7%   
Net fx Rs m-2-3 82.3%   
CASH FLOW
From Operations Rs m2212 174.6%  
From Investments Rs m-62-31 198.4%  
From Financial Activity Rs m4518 258.4%  
Net Cashflow Rs m5-1 -419.7%  

Share Holding

Indian Promoters % 49.1 49.2 99.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 0.8 85.0%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 50.8 100.1%  
Shareholders   15,737 9,305 169.1%  
Pledged promoter(s) holding % 47.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   PANACEA BIOTECH  MESCO PHARMA  GLAND PHARMA  SYNCOM FORMULATIONS  MEDICAMEN BI  



Today's Market

Sensex Trades Lower Tracking Weak Global Cues; IT & Energy Stocks Under Pressure(10:30 am)

Asian share markets are trading mostly lower today with lingering worries over a US rate hike partly offset by potentially positive news on the severity of the Omicron coronavirus variant.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Dec 6, 2021 11:18 AM

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA 5-YR ANALYSIS

COMPARE LACTOSE INDIA WITH

MARKET STATS